Literature DB >> 29023905

Cholangiopathy in critically ill patients surviving beyond the intensive care period: a multicentre survey in liver units.

L Laurent1, C Lemaitre2, A Minello3, A Plessier1, G Lamblin4, A Poujol-Robert5, A Gervais-Hasenknopf6, E-A Pariente7, P Belenotti8, N Mostefa-Kara9, P Sogni5, M Legrand5, J-M Cournac10, F Tamion2, G Savoye2, P Bedossa1,5, D-C Valla1,5, V Vilgrain1, O Goria2.   

Abstract

BACKGROUND: The outcome of cholangiopathy developing in intensive care unit (ICU) is not known in patients surviving their ICU stay. AIM: To perform a survey in liver units, in order to clarify the course of cholangiopathy after surviving ICU stay.
METHODS: The files of the liver units affiliated to the French network for vascular liver disease were screened for cases of ICU cholangiopathy developing in patients with normal liver function tests on ICU admission, and no prior history of liver disease.
RESULTS: Between 2005 and 2015, 16 cases were retrieved. Extensive burns were the cause for admission to ICU in 11 patients. Serum alkaline phosphatase levels increased from day 11 (2-46) to a peak of 15 (4-32) × ULN on day 81 (12-511). Magnetic resonance cholangiography showed irregularities or frank stenosis of the intrahepatic ducts, and proximal extrahepatic ducts contrasting with a normal aspect of the distal common bile duct. Follow-up duration was 20.6 (4.7-71.8) months. Three patients were lost to follow-up; 2 patients died from liver failure and no patient was transplanted. One patient had worsening strictures of the intrahepatic bile ducts with jaundice. Nine patients had persistent but minor strictures of the intrahepatic bile ducts on MR cholangiography, and persistent cholestasis without jaundice. One patient had normal liver function tests.
CONCLUSIONS: In patients surviving their ICU stay, ICU cholangiopathy is not uniformly fatal in the short term or clinically symptomatic in the medium term. Preservation of the distal common bile duct appears to be a finding differentiating ICU cholangiopathy from other diffuse cholangiopathies.
© 2017 John Wiley & Sons Ltd.

Entities:  

Mesh:

Year:  2017        PMID: 29023905     DOI: 10.1111/apt.14367

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  8 in total

1.  Impact of COVID-19 on the liver and on the care of patients with chronic liver disease, hepatobiliary cancer, and liver transplantation: An updated EASL position paper.

Authors:  Thomas Marjot; Christiane S Eberhardt; Tobias Boettler; Luca S Belli; Marina Berenguer; Maria Buti; Rajiv Jalan; Mario U Mondelli; Richard Moreau; Daniel Shouval; Thomas Berg; Markus Cornberg
Journal:  J Hepatol       Date:  2022-07-20       Impact factor: 30.083

2.  Critical Illness Cholangiopathy in COVID-19 Long-haulers.

Authors:  Nasir Saleem; Betty H Li; Raj Vuppalanchi; Samer Gawrieh; Mark A Gromski
Journal:  Tech Innov Gastrointest Endosc       Date:  2022-05-21

Review 3.  Secondary Sclerosing Cholangitis in Critically Ill Patients: An Underdiagnosed Entity.

Authors:  Pedro Martins; Mariana Verdelho Machado
Journal:  GE Port J Gastroenterol       Date:  2019-07-30

4.  High Rate of Gastrointestinal Bleeding in Patients with Secondary Sclerosing Cholangitis in Critically Ill Patients (SC-CIP).

Authors:  Andreas Blesl; Martin Eibisberger; Michael Schörghuber; Christoph Klivinyi; Vanessa Stadlbauer
Journal:  J Clin Med       Date:  2021-04-29       Impact factor: 4.241

Review 5.  Coronavirus Disease-2019 (COVID-19) and the Liver.

Authors:  Anshuman Elhence; Manas Vaishnav; Sagnik Biswas; Ashish Chauhan; Abhinav Anand
Journal:  J Clin Transl Hepatol       Date:  2021-03-22

6.  Secondary sclerosing cholangitis in critically ill patients: a rare disease precipitated by severe SARS-CoV-2 infection.

Authors:  Kate Edwards; Miles Allison; Sekina Ghuman
Journal:  BMJ Case Rep       Date:  2020-11-09

7.  Secondary Sclerosing Cholangitis in a Critically Ill Patient with Severe SARS-CoV-2 Infection: A Possibly Emergent Entity during the Current Global Pandemic.

Authors:  Bárbara Morão; Joana Branco Revés; Catarina Nascimento; Rui Loureiro; Luísa Glória; Carolina Palmela
Journal:  GE Port J Gastroenterol       Date:  2022-03-17

8.  Post-COVID-19 Secondary Sclerosing Cholangitis: A Rare but Severe Condition with no Treatment Besides Liver Transplantation.

Authors:  Marcel Cerqueira Cesar Machado; Roberto Kalil Filho; Ibrahim Ahmad Hussein El Bacha; Irai Santana de Oliveira; Cristiane Maria de Freitas Ribeiro; Heraldo Possolo de Souza; Edson Roberto Parise
Journal:  Am J Case Rep       Date:  2022-08-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.